Management of anxiety disorders: the added challenge of comorbidity (Q34218830)

31 July 2017

1 reference

title

Management of anxiety disorders: the added challenge of comorbidity (English)

1 reference

31 July 2017

1 reference

Dunner DL

1

1 reference

31 July 2017

publication date

1 January 2001

1 reference

31 July 2017

published in

Depression and Anxiety

1 reference

31 July 2017

volume

13

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

57-71

1 reference

Clomipramine and diazepam in the treatment of agoraphobia and social phobia in general practice

31 July 2017

cites work

1 reference

Lifetime comorbidity of panic attacks and major depression in a population-based study. Symptom profiles.

21 January 2018

1 reference

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

21 January 2018

1 reference

Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder

21 January 2018

1 reference

School phobia: a therapeutic trial with clomipramine and short-term outcome

21 January 2018

1 reference

Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia

21 January 2018

1 reference

Traumatic events and posttraumatic stress disorder in an urban population of young adults

21 January 2018

1 reference

Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice

21 January 2018

1 reference

Double-blind pilot trial of desipramine versus fluoxetine in panic patients

21 January 2018

1 reference

Clomipramine for panic disorder: I. The first 10 weeks of a long-term comparison with imipramine.

21 January 2018

1 reference

Discontinuation of clonazepam in the treatment of social phobia.

21 January 2018

1 reference

A meta-analysis of treatments for panic disorder with agoraphobia: imipramine, alprazolam, and in vivo exposure

21 January 2018

1 reference

Drug therapy of post-traumatic stress disorder

21 January 2018

1 reference

Treatment of posttraumatic stress disorder with amitriptyline and placebo.

21 January 2018

1 reference

Fluvoxamine treatment for chronic PTSD: a pilot study

21 January 2018

1 reference

Academic medical center/industry collaboration

21 January 2018

1 reference

The Zurich study. XX. Social phobia and agoraphobia

21 January 2018

1 reference

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

21 January 2018

1 reference

Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.

21 January 2018

1 reference

Selective Serotonin Reuptake Inhibitors: Pharmacologic Profiles and Potential Therapeutic Distinctions

21 January 2018

1 reference

A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder

21 January 2018

1 reference

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

21 January 2018

1 reference

Comorbid depression and anxiety spectrum disorders

21 January 2018

1 reference

Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder

21 January 2018

1 reference

Comorbid psychiatric disorders in PTSD. Implications for research

21 January 2018

1 reference

Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey

21 January 2018

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

Posttraumatic stress disorder in the National Comorbidity Survey

21 January 2018

1 reference

Citalopram in the treatment of obsessive-compulsive disorder: an open pilot study.

21 January 2018

1 reference

Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder

21 January 2018

1 reference

The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder

21 January 2018

1 reference

Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism

21 January 2018

1 reference

Suicide attempts in patients with panic disorder.

21 January 2018

1 reference

Classification and epidemiology of social phobia

21 January 2018

1 reference

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

21 January 2018

1 reference

Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey

21 January 2018

1 reference

Behaviour therapy for obsessive-compulsive disorder: a decade of progress

21 January 2018

1 reference

An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder.

21 January 2018

1 reference

Comorbidity and social phobia: evidence from clinical, epidemiologic, and genetic studies

21 January 2018

1 reference

Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.

21 January 2018

1 reference

Six-month prevalence of psychiatric disorders in three communities 1980 to 1982.

21 January 2018

1 reference

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.

21 January 2018

1 reference

Controlled comparisons of clomipramine and fluoxetine in the treatment of obsessive-compulsive disorder. Behavioral and biological results

21 January 2018

1 reference

Sertraline in the treatment of panic disorder: a double-blind multicenter trial.

21 January 2018

1 reference

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

Comorbidity of panic and major depressive disorder

21 January 2018

1 reference

Sertraline in the treatment of rape victims with posttraumatic stress disorder.

21 January 2018

1 reference

Social phobia. Comorbidity and morbidity in an epidemiologic sample

21 January 2018

1 reference

The life-time rates of three major mood disorders and four major anxiety disorders in alcoholics and controls

21 January 2018

1 reference

Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine

21 January 2018

1 reference

Treatment of posttraumatic stress disorder: a review.

21 January 2018

1 reference

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

21 January 2018

1 reference

A controlled trial of phenelzine in posttraumatic stress disorder.

21 January 2018

1 reference

Imipramine in the treatment of social phobia.

21 January 2018

1 reference

Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation.

21 January 2018

1 reference

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

21 January 2018

1 reference

Moclobemide and fluoxetine for panic disorder. International Panic Disorder Study Group

21 January 2018

1 reference

Response of panic disorder to fixed doses of alprazolam or imipramine.

21 January 2018

1 reference

Sertraline in social phobia.

21 January 2018

1 reference

Anxious depressions. Clinical, family history, and naturalistic outcome--comparisons with panic and major depressive disorders.

21 January 2018

1 reference

Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor

21 January 2018

1 reference

A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder

21 January 2018

1 reference

Pharmacotherapy of Social Phobia

21 January 2018

1 reference

The Zurich Study. IX. Panic disorder and sporadic panic: symptoms, diagnosis, prevalence, and overlap with depression.

21 January 2018

1 reference

Suicidal behavior in patients with panic disorder: retrospective and prospective data

21 January 2018

1 reference

Social phobia in general health care: an unrecognised undertreated disabling disorder

21 January 2018

1 reference

Prevalence of mental disorders and psychosocial impairments in adolescents and young adults

21 January 2018

1 reference

Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators

21 January 2018

1 reference

Alcohol dependence and anxiety disorders: what is the relationship?

21 January 2018

1 reference

Treatment of social phobia with clonazepam and placebo.

21 January 2018

1 reference

A Comparison of Fluvoxamine, Cognitive Therapy, and Placebo in the Treatment of Panic Disorder

21 January 2018

1 reference

Social phobia: the nature of the disorder

21 January 2018

1 reference

Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis

21 January 2018

1 reference

Comorbidity of anxiety, phobia, compulsion and depression

21 January 2018

1 reference

A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder

21 January 2018

1 reference

Paroxetine in social phobia/social anxiety disorder. Randomised, double-blind, placebo-controlled study. Paroxetine Study Group

21 January 2018

1 reference

How psychiatrists can build new therapies for impotence

21 January 2018

1 reference

Cessation of self-mutilation in a patient with borderline personality disorder treated with naltrexone

21 January 2018

1 reference

Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators

21 January 2018

1 reference

Post-traumatic stress disorder in the community: an epidemiological study

21 January 2018

1 reference

The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study.

21 January 2018

1 reference

Predicting response to amitriptyline in posttraumatic stress disorder

21 January 2018

1 reference

The Galway Study of Panic Disorder. I: Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial

21 January 2018

1 reference

Obsessive-compulsive disorder among patients entering substance abuse treatment. Prevalence and accuracy of diagnosis

21 January 2018

1 reference

Refining treatment approaches in obsessive-compulsive disorder

21 January 2018

1 reference

Combined pharmacotherapy and cognitive behavior therapy in the treatment of panic disorder

21 January 2018

1 reference

The infrequency of "pure culture" diagnoses among the anxiety disorders.

21 January 2018

1 reference

Clinical characteristics of patients with concurrent major depressive disorder and panic disorder

21 January 2018

1 reference

Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder

21 January 2018

1 reference

Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic

21 January 2018

1 reference

Sertraline for social phobia: a double-blind, placebo-controlled crossover study

21 January 2018

1 reference

Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo

21 January 2018

1 reference

DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES

21 January 2018

1 reference

Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison

21 January 2018

1 reference

A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators

21 January 2018

1 reference

Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators

21 January 2018

1 reference

Citalopram in the treatment of social phobia: a report of three cases

21 January 2018

1 reference

A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder

21 January 2018

1 reference

Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation

21 January 2018

1 reference

Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study

21 January 2018

1 reference

Comorbidity of panic disorder, phobia, and major depression

21 January 2018

1 reference

Paroxetine in social phobia.

21 January 2018

1 reference

Clomipramine and exposure for obsessive-compulsive rituals: i

21 January 2018

1 reference

Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group

21 January 2018

1 reference

Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study Group

21 January 2018

1 reference

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group

21 January 2018

1 reference

Early response with clomipramine in obsessive compulsive disorder--a placebo controlled study

21 January 2018

1 reference

An open trial of moclobemide in the treatment of post-traumatic stress disorder

21 January 2018

1 reference

Moclobemide in social phobia: a controlled dose-response trial

21 January 2018

1 reference

Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

Social phobia and clonazepam

21 January 2018

1 reference

A 2-year study of sertraline in the treatment of obsessive-compulsive disorder.

21 January 2018

1 reference

A controlled trial of desipramine in 18 men with posttraumatic stress disorder

21 January 2018

1 reference

New developments in obsessive-compulsive disorder research: implications for clinical management.

21 January 2018

1 reference

Prospective follow-up study lasting 2 years in patients with panic disorder with and without depressive disorders

21 January 2018

1 reference

Placebo-controlled trial of moclobemide in social phobia

21 January 2018

1 reference

A 2-year follow-up of social phobia. Status after a brief medication trial

21 January 2018

1 reference

The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities

21 January 2018

1 reference

Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial

21 January 2018

1 reference

Alcohol abuse among clinically anxious patients

21 January 2018

1 reference

A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder

21 January 2018

1 reference

Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial

21 January 2018

1 reference

A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments

21 January 2018

1 reference

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

21 January 2018

1 reference

Clomipramine and imipramine in obsessive-compulsive disorder

21 January 2018

1 reference

The effect of citalopram in panic disorder

21 January 2018

1 reference

Monoamine oxidase inhibitors: safety and efficacy issues

21 January 2018

1 reference

7 January 2021

Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline

1 reference

7 January 2021

Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine

1 reference

7 January 2021

Clinical implications of the pharmacology of serotonin reuptake inhibitors

1 reference

7 January 2021

A post hoc comparison of paroxetine and nortriptyline for symptoms of traumatic grief

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.1018

1 reference

31 July 2017

1 reference